Inceptionr »

Supernus Pharmaceuticals shares owned by Inceptionr

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Inceptionr from 13F filings

Historical chart of Inceptionr investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Inceptionr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Inceptionr

Quarter filed Position value Share count Share price at filing
2026-06-30 $686k 15k 46.51

More positions owned by Inceptionr

Corteva (CTVA)
Gilead Sciences (GILD)
Raymond James Financial (RJF)
Aercap Holdings Nv SHS (AER)
Prudential Financial (PRU)
Boeing Company (BA)
Franklin Resources (BEN)
Ameriprise Financial (AMP)
ConocoPhillips (COP)
Ionis Pharmaceuticals (IONS)
Ingredion Incorporated (INGR)
Gra (GGG)
Exxon Mobil Corporation (XOM)
State Street Corporation (STT)
T. Rowe Price (TROW)

View all positions for Inceptionr

Top funds holding Supernus Pharmaceuticals

BlackRock
Millennium Management
Vanguard Portfolio Management
Armistice Capital
Vanguard Capital Management
Nomura Asset Management International
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Stephens Investment Management Group
Renaissance Technologies
Loomis, Sayles and
Citadel Advisors
Two Sigma Investments
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals